Akari Therapeutics (AKTX) Interest & Investment Income (2014 - 2025)
Akari Therapeutics' (AKTX) quarterly Interest & Investment Income came in at $1000.0 in Q3 2025, down 66.67% year-on-year from $3000.0 in Q3 2024, and little changed quarter-over-quarter from $1000.0 in Q4 2024.
Akari Therapeutics (AKTX) Interest & Investment Income (2014 - 2025) Analysis & Trends
Akari Therapeutics has disclosed Interest & Investment Income across 8 years of filings, most recently posting $1000.0 for Q3 2025.
- Interest & Investment Income for Q3 2025 came in at $1000.0, down 66.67% year-over-year; the trailing twelve-month figure through Dec 2025 was $5000.0 (down 37.5% YoY), and the FY2025 annual result was $1000.0, down 87.5% from the prior year.
- Interest & Investment Income came in at $1000.0 for Q3 2025 at Akari Therapeutics, roughly flat from $1000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $30000.0 in Q1 2023 to a low of $1000.0 in Q4 2024.
- The 3-year median for Interest & Investment Income is $3000.0 (2024), against an average of $10111.1.
- Across the five-year window, Interest & Investment Income slumped 93.33% in 2024 and sank 66.67% in 2025, its largest moves.
- Akari Therapeutics' Interest & Investment Income stood at $7000.0 in 2023, then sank by 85.71% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025.
- The last three Interest & Investment Income figures came in at $1000.0 (Q3 2025), $1000.0 (Q4 2024), and $3000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 16,000.00 |
| Jun 30, 2023 | 29,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Dec 31, 2020 | 5,321.00 |
| Sep 30, 2020 | 6,132.00 |
| Jun 30, 2020 | 1,152.00 |
| Mar 31, 2020 | 1,010.00 |
| Dec 31, 2019 | 1,739.00 |
| Sep 30, 2019 | 2,057.00 |
| Jun 30, 2019 | 449.00 |
| Mar 31, 2019 | 1,286.00 |
| Mar 31, 2016 | 30,804.00 |
| Dec 31, 2015 | 19,260.00 |
| Sep 30, 2015 | 1,445.00 |